Envíos recientes

Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies

León-Román, Juan; Bolufer Cardona, Monica; Sánchez-Salinas, Mario; Alonso-Martínez, Carla; Bestard, Oriol; Bermejo García, Sheila; Cecilia del Carmen, Carpio Segura; Garcia-Carro, Clara; Barba, Pere; Soler, María José; IACOBONI, GLORIA (Oxford University Press, 2024-03)

Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study

Krajewska, Jolanta; Hernando, Jorge; Robinson, Bruce; Capdevila Castillon, Jaume; Sherman, Steven; Jarząb, Barbara (Mary Ann Liebert, 2024-03)

Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis

Arellano-Rodrigo, Eduardo; Garrote Ordeig, Marta; Martín, Iván; GOMEZ CASARES, MARIA TERESA; Mosquera Orgueira, Adrián; Pérez-Encinas, Manuel; Fox, Maria Laura (Wiley, 2024-03-20)

Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trial

Fakih, Marwan; Prager, M.D., Gerald; Van Cutsem, Eric; Tabernero, Josep; taieb, julien; Ciardiello, Fortunato (Elsevier, 2024-03)

Cell type signatures in cell-free DNA fragmentation profiles reveal disease biology

Stanley, Kate; Jatsenko, Tatjana; Tuveri, Stefania; Sudhakaran, Dhanya; Lannoo, Lore; Van Calsteren, Kristel; Toledo, Rodrigo (Nature Research, 2024-03-12)

Scientia. Depósito de Información Digital del Departamento de Salud

VHIO - Articles científics: Envíos recientes

Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies

Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study

Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis

Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trial

Cell type signatures in cell-free DNA fragmentation profiles reveal disease biology

Scientia. Depósito de Información Digital del Departamento de Salud

VHIO - Articles científics: Envíos recientes

Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies ﻿

Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study ﻿

Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis ﻿

Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trial ﻿

Cell type signatures in cell-free DNA fragmentation profiles reveal disease biology ﻿

Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies

Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study

Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis

Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trial

Cell type signatures in cell-free DNA fragmentation profiles reveal disease biology